Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma.
Journal: Blood cancer journal
Published: April 17, 2026
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
Journal: Blood cancer journal
Published: July 01, 2025
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy.
Journal: Bone marrow transplantation
Published: October 24, 2022
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
Journal: American journal of hematology
Published: July 04, 2022
COVID-19 and acute pancreatitis: A systematic review.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: February 14, 2022
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
Journal: American journal of hematology
Published: January 25, 2022
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
Journal: Journal of clinical medicine
Published: January 06, 2022
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma.
Journal: Cancers
Published: July 06, 2021
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
Journal: Haematologica
Published: April 12, 2021
A Rapidly Fatal Infection With Haemophilus influenzae Serotype E Harboring bla ROB-1: The Dilemma of Safe De-escalation in the Setting of Potential Extended-Spectrum β-Lactamase Production.
Journal: Open forum infectious diseases
Published: September 17, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026